Gantzert Investment Company’s Pfizer PFE Stock Holding History

Gantzert Investment Company’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$1.96M	Buy	56,326 +738	+1%	+$25.9K	1.77%	24
2020 Q2	$1.73M	Sell	55,588 -16	-0%	-$544	1.69%	27
2020 Q1	$1.72M	Sell	55,604 -211	-0.4%	-$7.19K	1.85%	25
2019 Q4	$2.08M	Sell	55,815 -263	-0.5%	-$9.37K	1.9%	27
2019 Q3	$1.91M	Sell	56,078 -422	-0.7%	-$15.3K	1.87%	27
2019 Q2	$2.32M	Sell	56,500 -369	-0.6%	-$14.7K	2.29%	17
2019 Q1	$2.29M	Buy	56,869 +140	+0.2%	+$5.61K	2.32%	18
2018 Q4	$2.35M	Buy	+56,729	New	+$2.35M	2.62%	12

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Gantzert Investment Company's PFE Position: Q3 2020 in Review

Gantzert Investment Company increased its Pfizer (PFE) stake by 1.3% in Q3 2020, buying an estimated $25.9K and bringing the position to 56,326 shares worth $1.96M. The position accounts for 1.77% of the portfolio, ranked #24.

Gantzert Investment Company first reported a position in PFE in Q4 2018 and has held it in 8 quarters since. The position peaked at $2.35M in Q4 2018. 2,509 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

Gantzert Investment Company held 56,326 shares of Pfizer worth $1.96M as of Q3 2020.
Gantzert Investment Company bought 738 Pfizer shares in Q3 2020, an estimated $25.9K.
Pfizer made up 1.77% of Gantzert Investment Company's portfolio in Q3 2020, its #24 holding.
Gantzert Investment Company first reported a position in Pfizer in Q4 2018 and has held it in 8 quarters since.
Gantzert Investment Company's Pfizer position peaked at $2.35M in Q4 2018.
2,509 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on Gantzert Investment Company's 13F filing for Q3 2020, filed 7 Oct 2020.